Cornerstone Therapeutics Delisted
Organization: Chiesi USA
Short Description: Chiesi USA is a pharmaceutical company dedicated to developing and commercializing products that address the needs of healthcare providers and their patients. They strive to improve the lives of patients by delivering innovative products and associated services. Chiesi USA focuses on discovering and developing medical solutions to meet unmet needs in the healthcare industry.
Investors Number:
1
Total Funding:
$0
Last Funding Date:
15.05.2012
Technology:
Specific disorder-related
Estimated Revenue:
$10-50 Mn
Founded Date:
01.01.2000
Employee Number:
51-100
Industry:
PharmTech
Headquarters:
Cary, USA
Funding Status:
Acquired/Merged
Last Funding Type:
EKR Therapeutics acquired by Cornerstone Therapeutics